Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development IntensifiesBenzinga • 04/09/20
Covid Report: Pfizer Selects Lead Coronavirus Drug; Gilead Updates TestsInvestors Business Daily • 04/09/20
Pfizer and BioNTech Aim to Start Testing Coronavirus Vaccines in Humans by Late AprilThe Motley Fool • 04/09/20
Will the Pfizer-BioNTech Collaboration Be a Winner in the Fight Against COVID-19?24/7 Wall Street • 04/09/20
Pfizer discloses $185 million upfront payment to BioNTech for COVID-19 vaccine programMarket Watch • 04/09/20
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine DevelopmentGlobeNewsWire • 04/09/20
Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 PandemicThe Motley Fool • 04/02/20
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be PrematureThe Motley Fool • 04/01/20